Last 124.50 GBp
Change Today 0.00 / 0.00%
Volume 13.6K
As of 11:35 AM 02/27/15 All times are local (Market data is delayed by at least 15 minutes).

microgen plc (MCGN) Snapshot

Open
124.50 GBp
Previous Close
124.50 GBp
Day High
124.50 GBp
Day Low
124.50 GBp
52 Week High
03/3/14 - 135.50 GBp
52 Week Low
12/15/14 - 117.00 GBp
Market Cap
92.9M
Average Volume 10 Days
175.6K
EPS TTM
0.05 GBp
Shares Outstanding
74.6M
EX-Date
05/14/15
P/E TM
25.2x
Dividend
3.67 GBp
Dividend Yield
2.95%
Current Stock Chart for MICROGEN PLC (MCGN)

Related News

No related news articles were found.

microgen plc (MCGN) Related Businessweek News

No Related Businessweek News Found

microgen plc (MCGN) Details

Microgen plc, together with its subsidiaries, provides information technology services and solutions in the United Kingdom, Ireland, and internationally. The company offers software licences, maintenance, support, funded development, and related consultancy services. It operates through Aptitude Software and Financial Systems segments. The Aptitude Software business provides enterprise level application products and solutions for processing of business event-driven transactions. The Financial Systems division offers a portfolio of back office processing software to the banking, wealth management, and energy sectors. The company also provides consulting, application management, product support, and training and accreditation services Microgen plc was founded in 1974 and is headquartered in London, the United Kingdom.

Founded in 1974

microgen plc (MCGN) Top Compensated Officers

Executive Chairman, Member of The Operating B...
Total Annual Compensation: 275.0K GBP
Group Finance Director, Executive Director an...
Total Annual Compensation: 206.7K GBP
Compensation as of Fiscal Year 2014.

microgen plc (MCGN) Key Developments

Microgen plc Reports Audited Preliminary Earnings Results for the Year Ended December 31, 2014; Recommends Final Dividend, Payable on June 15, 2015

Microgen plc reported audited preliminary earnings results for the year ended December 31, 2014. For the period, the company reported revenue of GBP 29,814,000 against GBP 29,824,000 a year ago. Operating profit was GBP 6,161,000 against GBP 8,688,000 a year ago. Profit before income tax was GBP 5,766,000 against GBP 8,688,000 a year ago. Profit for the year was GBP 4,113,000 or 5.1 pence per diluted share against GBP 6,438,000 or 7.7 pence per diluted share a year ago. Net cash flows generated from operating activities were GBP 7,915,000 against GBP 6,256,000 a year ago. Purchase of property, plant and equipment was GBP 612,000 against GBP 427,000 a year ago. Adjusted diluted earnings per share was 6.7 pence. Adjusted profit on ordinary activities after tax was GBP 5,416,000 against GBP 6,783,000 a year ago. Benefitting from continued tight cost control, the business reported strong adjusted operating profits of GBP 7.5 million compared to GBP 8.1 million in 2013, representing an adjusted operating margin of 52% compared to 54% in 2013. The Board is recommending a final dividend of 2.2 pence per share representing a full year dividend of 3.3 pence compared to 3.3 pence in addition to a special dividend of 5.2 pence in 2013. Subject to shareholder approval, the proposed final dividend will be payable on 15 June 2015 to shareholders on the register at the close of business on 14 May 2015.

Microgen Seeks Acquisitions

Microgen plc (LSE:MCGN) had acquired Unity Software Limited. Unity will be integrated into Microgen's Financial Systems business. A key element of the strategy of the Financial Systems' business is to increase the proportion of its revenue derived from the wealth management sector through add-on acquisitions.

Microgen and China National Biotec Group to Co-Operate in Vaccine Production

Microgen will co-operate with China National Biotec Group in the field of biopharmaceutical products. The agreement for 'strategic and technical co-operation' includes the introduction of innovative technologies within Russian production and the provision of vaccines for infection prevention. According to the agreement, the clinical trials in Russia for the Chinese organisation's vaccines are set to commence in 2015, with the procurement of the company's products for the purpose of domestic supply anticipated in 2016. The technology transfer is planned to be completed by 2020.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MCGN:LN 124.50 GBp 0.00

MCGN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Anite PLC 90.75 GBp -0.25
Bottomline Technologies de Inc $26.48 USD -0.55
Phoenix IT Group PLC 132.50 GBp 0.00
Spirent Communications PLC 92.75 GBp -1.50
Xchanging Solutions Ltd 38.05 INR +1.75
View Industry Companies
 

Industry Analysis

MCGN

Industry Average

Valuation MCGN Industry Range
Price/Earnings 24.1x
Price/Sales 3.1x
Price/Book 1.6x
Price/Cash Flow 22.4x
TEV/Sales 3.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MICROGEN PLC, please visit www.microgen.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.